Anaesthesia drugs market controlled by Abbott Laboratories, AstraZeneca, and Baxter International

The global anaesthesia drugs market has been forecast to increase at a compound annual growth rate (CAGR) of 2.53% through to 2016, hitting a market value of $7 billion.

Key factors set to drive growth within the industry include the rise in the number of emergency surgeries, and the pediatrics applications of anaesthesia.

An anaesthetic is a drug that causes anaesthesia - a reversible loss of sensation. These drugs are generally administered to facilitate surgery. A wide variety of drugs are used in modern anaesthetic practice. Many are rarely used outside of anaesthesia, although others are used commonly by all disciplines.

Anaesthetics are categorised into two classes: general anaesthetics, which cause a reversible loss of consciousness, and local anaesthetics, which cause a reversible loss of sensation for a limited region of the body while maintaining consciousness.

One of the main drivers in this market is the increasing aging population across the world. The aging population across the world is expected to increase massively by 2050. This increase in the aging population results in increased surgeries, which in turn leads to increased use of anaesthesia drugs.

Ketamine is an anaesthetic drug mainly used for initiation and maintenance of general anaesthesia in humans. It belongs to NMDA receptor antagonist class, which includes molecules that prevent the action of the N-methyl D-aspartate (NMDA) receptor.

Factors such as increase in the aging population, rising cardiovascular, and respiratory system related diseases and the rising number of emergency surgeries will help in maintaining stable growth in ketamine market revenue in the next five years.

Several hundred companies compete worldwide in the anaesthesia drug market. Companies in the market consist of large pharmaceutical companies, niche pain management and anaesthesia drug manufacturers, and worldwide generic drug providers.

Key companies currently dominating the anaesthesia drugs market include Abbott Laboratories, AstraZeneca PLC, and Baxter International Inc.

For more information on the anaesthesia drugs market, see the latest research: Anaesthesia Drugs Market

Follow us on Twitter @CandMResearch